跳至主要内容
临床试验/CTRI/2024/02/062367
CTRI/2024/02/062367尚未招募2 期

Randomised controlled assessor-blind trial to compare the efficacy of tofacitinib v/s methotrexate in patients with moderate to severe atopic dermatitis - NI

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients >2 years of age with moderate to severe atopic dermatitis (SCORAD >25)

排除标准

  • 1.Patients with latent and active tuberculosis.
  • 2.Patients receiving systemic immunosuppressive therapy in last 1 month.
  • 3.Patients unable to come for follow up.
  • 4.History of immunization with live vaccines in last 4 weeks.
  • 5.Pregnant and lactating females.
  • 6.Patients with history of thromboembolic phenomenon or on anti-coagulants.

研究者

相似试验